ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2026
Construction of a Risk Prediction Model and Associative Path Analysis for Impaired Awareness of Hypoglycemia in People with Diabetes.
Article in Diabetes, metabolic syndrome and obesity : targets and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: We aimed to develop a risk prediction model for impaired awareness of hypoglycemia (IAH) in diabetes and explore the associations with clinical variables, providing a basis for targeted screening and personalized intervention. Patients and Methods: This cross-sectional study included 280 hospitalized people with diabetes (73.2% type 2 and 42.9% female) who experienced hypoglycemia between October 2023 and February 2024. We defined IAH as a Gold Scale score ≥4. We used binary logistic regression to construct the prediction model and structural equation modeling to analyze the associated pathways. Sensitivity analysis stratified by diabetes type verified the robustness of the results. Results: IAH affected 60.4% of the participants. Multivariate analysis revealed lower total cholesterol (TC) levels (aOR=0.819; 95% CI: 0.684-0.981; P=0.030) as independent correlates. The model, which incorporated BMI, TC level, serum albumin level, peripheral neuropathy (PN) incidence, glomerular filtration rate (GFR), age, sex, and insulin use, showed moderate discriminative ability (AUC=0.630, P<0.001), with high sensitivity (87.0%) and good calibration (Hosmer-Lemeshow test: P=0.743). Path analysis revealed that age indirectly influenced IAH risk (β=0.243) by decreasing the GFR (β=-0.419; P<0.001) and increasing PN risk (β=0.352; P<0.001) and that a lower GFR (β=-0.133; P=0.024) and TC level (β=-0.131; P=0.024) were directly correlated with IAH risk. The serum albumin level was maintained by preserving the GFR (β=0.203; P<0.001) and reducing PN risk (β=-0.139; P=0.012). Conclusion: Higher BMI and lower TC are key correlates of IAH in hospitalized patients with diabetes. Age, GFR, serum albumin, and PN interact through direct and indirect pathways to affect the risk of IAH. This model, based on routine clinical indicators and with high sensitivity, represents a practical screening tool. Clinicians should perform early risk assessment and intervention in diabetic patients with higher BMI, lower TC, advanced age, malnutrition, renal insufficiency, or PN.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.